Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668

2005 ◽  
Vol 91 (2) ◽  
pp. 133-144 ◽  
Author(s):  
C. K. Fog ◽  
I. J. Christensen ◽  
A. E. Lykkesfeldt
2002 ◽  
Vol 129 (1-2) ◽  
pp. 55-63 ◽  
Author(s):  
Christel M Olsen ◽  
Elise T.M Meussen-Elholm ◽  
Jørn A Holme ◽  
Jan K Hongslo

Endocrinology ◽  
1987 ◽  
Vol 121 (5) ◽  
pp. 1759-1765 ◽  
Author(s):  
ANNE-MARIE NUNEZ ◽  
SONIA JAKOWLEV ◽  
JEAN-PAUL BRIAND ◽  
MIREILLE GAIRE ◽  
ANDRÉE KRUST ◽  
...  

1992 ◽  
Vol 292 (1) ◽  
pp. 136-140 ◽  
Author(s):  
Ryuji Kitamura ◽  
Keiko Sato ◽  
Minoru Sawada ◽  
Susumu Itoh ◽  
Mitsukazu Kitada ◽  
...  

2021 ◽  
Vol 66 (1) ◽  
pp. 65-71
Author(s):  
Hung Nguyen Phi ◽  
Toan Tran Quoc ◽  
Tuan Nguyen Anh ◽  
Vy Trinh Ngoc Thao ◽  
Yen Ngo Thi Ngoc ◽  
...  

Three alkaloids (named rutaecarpine (1), evodiamine (2), schinifoline (3) and one phenylpropanoid, integrifoliodiol (4)) have been isolated from the EtOAc extract of the fruits of Tetradium ruticarpum (A. Juss.) T. G. Hartley collected in Lang Son province. Their structures have been identified by using 1D and 2D NMR spectroscopies. All four compounds were tested for their cytotoxicity against the human breast cancer cell line (MCF-7) and tamoxifen-resistant breast cancer cell line (MCF\TAMR). The results showed that rutaecarpine (1) inhibited the growth of MCF7 and MCF\TAMR with its IC50 values of 41.2 and 64.6 µM, respectively. In addition, compounds 1, 2, and 4 showed moderate activity toward MCF-7 cell line.


2003 ◽  
Vol 32 (8) ◽  
pp. 1595-1603 ◽  
Author(s):  
J. Vassy ◽  
S. Portet ◽  
M. Beil ◽  
G. Millot ◽  
F. Fauvel-Lafève ◽  
...  

2019 ◽  
Vol 15 (60) ◽  
pp. 66
Author(s):  
Naser Abbasi ◽  
Roohangiz Mameneh ◽  
Massoumeh Shafiei ◽  
Ali Aidy ◽  
Elahe Karimi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document